With a market cap of $356.2 billion, North Chicago, Illinois-based AbbVie Inc. (ABBV) operates in the pharmaceutical sector.

AbbVie has a lower P/E than the aggregate P/E of 112.06 of the Biotechnology industry. Ideally, one might believe that the ...

You can be a little greedy sometimes and find great stocks that possess solid growth prospects and also pay dividends.

ABBV) have crossed above the average analyst 12-month target price of $202.46, changing hands for $203.87/share. When a stock reaches the target an analyst has set, the analyst logically has two ...

Option chain shows key data for AbbVie's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for AbbVie.

had a $354.1 billion market cap, putting it in the 100th percentile of all stocks. AbbVie Inc.’s stock is up 29.4% in 2024, up 5.8% in the previous five trading days and up 39.93% in the past year.

(NYSE:ABBV) reported a robust third quarter for 2024, with sales exceeding expectations and significant growth in key product segments.... AbbVie Inc . (NYSE:ABBV) has reached a remarkable milestone, ...

AbbVie Inc. Stock News As of November 6, 2024, Gilead Sciences, Inc. had a $112.3 billion market capitalization, compared to the Biotechnology median of $151.8 million. Gilead Sciences, Inc.’s stock ...

This month, we explore the 125-year-old history of ... company – AbbVie. In January 2013, AbbVie was formed. It began trading independently on the New York Stock Exchange on the 2nd January ...